These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA, Decruyenaere JM. Nephrol Dial Transplant; 2005 Mar; 20(3):552-8. PubMed ID: 15671075 [Abstract] [Full Text] [Related]
8. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation. Kim SW, Kami M, Urahama N, Yamamoto R, Hori A, Imataki O, Kanda Y, Tanosaki R, Mineishi S, Takaue Y, Honda O. Transplantation; 2003 Feb 27; 75(4):566-70. PubMed ID: 12605131 [Abstract] [Full Text] [Related]
9. Survival in a recent cohort of mechanically ventilated pediatric allogeneic hematopoietic stem cell transplantation recipients. van Gestel JP, Bollen CW, Bierings MB, Boelens JJ, Wulffraat NM, van Vught AJ. Biol Blood Marrow Transplant; 2008 Dec 27; 14(12):1385-93. PubMed ID: 19041061 [Abstract] [Full Text] [Related]
10. Safety of percutaneous dilational tracheostomy in hematopoietic stem cell transplantation recipients requiring long-term mechanical ventilation. Kluge S, Baumann HJ, Nierhaus A, Kröger N, Meyer A, Kreymann G. J Crit Care; 2008 Sep 27; 23(3):394-8. PubMed ID: 18725046 [Abstract] [Full Text] [Related]
11. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis. van Gestel JP, Bollen CW, van der Tweel I, Boelens JJ, van Vught AJ. Crit Care Med; 2008 Oct 27; 36(10):2898-904. PubMed ID: 18766109 [Abstract] [Full Text] [Related]
15. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant. Cheuk DK, Ha SY, Lee SL, Chan GC, Tsoi NS, Lau YL. Hematol Oncol; 2004 Mar 27; 22(1):1-9. PubMed ID: 15152366 [Abstract] [Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 27; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
18. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY. Biol Blood Marrow Transplant; 2009 Feb 27; 15(2):266-73. PubMed ID: 19167687 [Abstract] [Full Text] [Related]
19. Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid. Wanko SO, Broadwater G, Folz RJ, Chao NJ. Biol Blood Marrow Transplant; 2006 Sep 27; 12(9):949-53. PubMed ID: 16920561 [Abstract] [Full Text] [Related]
20. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Michallet M, Le QH, Mohty M, Prébet T, Nicolini F, Boiron JM, Esperou H, Attal M, Milpied N, Lioure B, Bordigoni P, Yakoub-Agha I, Bourhis JH, Rio B, Deconinck E, Renaud M, Chir Z, Blaise D. Exp Hematol; 2008 May 27; 36(5):535-44. PubMed ID: 18346838 [Abstract] [Full Text] [Related] Page: [Next] [New Search]